Syndax Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
syndax pharmaceuticals報告根據納斯達克上市規則5635(C)(4)的誘因授予
Syndax Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
syndax pharmaceuticals報告根據納斯達克上市規則5635(C)(4)的誘因授予
譯文內容由第三人軟體翻譯。